n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine has been researched along with fumonisin b1 in 1 studies
Studies (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Trials (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Recent Studies (post-2010) (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Studies (fumonisin b1) | Trials (fumonisin b1) | Recent Studies (post-2010) (fumonisin b1) |
---|---|---|---|---|---|
78 | 0 | 12 | 1,484 | 14 | 454 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boldin, S; Futerman, AH | 1 |
1 other study(ies) available for n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and fumonisin b1
Article | Year |
---|---|
Glucosylceramide synthesis is required for basic fibroblast growth factor and laminin to stimulate axonal growth.
Topics: 4-Chloro-7-nitrobenzofurazan; Antineoplastic Agents; Axons; Carboxylic Acids; Cell Polarity; Cells, Cultured; Ceramides; Fibroblast Growth Factor 2; Fumonisins; Glucosylceramides; Hippocampus; Laminin; Morpholines; Neurons; Polylysine; Stereoisomerism; Teratogens | 1997 |